Galena Biopharma In (GALE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GALE | SNGX | GDTC | ||
| Company | Galena Biopharma In | Soligenix Inc | Cytomed Therapeutics Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.29 | 1.2100 | 1.0000 | ||
| High | 0.40 | 1.2200 | 1.0000 | ||
| Low | 0.26 | 1.1572 | 1.0000 | ||
| Latest | 0.26 | 1.1900 | 1.0000 | ||
| Change | -0.02 | +0.0100 | unch | ||
| % Change | -7.14% | +0.85% | unch | ||
| Volume | 20,353,201 | 36,232 | 1,662 | ||
| 20-Day Average Volume | 1,645,400 | 337,792 | 7,148 | ||
| Previous Close | 0.28 | 1.1800 | 1.0000 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.28 | 1.1990 | 1.0450 | ||
| 20-Day Raw Stochastic | 0.00% | 59.38% | 24.55% | ||
| 20-Day Relative Strength | 39.37 | 48.71 | 42.89 | ||
| Weighted Alpha | -71.76 | -34.92 | -65.93 | ||
| Today's Opinion | N/A | 88% Sell | 88% Sell | ||
| Previous Opinion | N/A | 88% Sell | 88% Sell | ||
| Last Month's Opinion | N/A | 88% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.45% since 12/22/17 | -0.83% since 03/25/26 | -5.66% since 03/25/26 | ||
| Low | 0.26 on 12/29/17 | 1.0000 on 03/26/26 | 1.0000 on 04/01/26 | ||
| High | 0.40 on 12/29/17 | 1.2300 on 03/26/26 | 1.0400 on 03/27/26 | ||
| 1-Month | |||||
| %Chg | -16.40% since 11/29/17 | +0.85% since 02/27/26 | -7.41% since 02/27/26 | ||
| Low | 0.26 on 12/29/17 | 1.0000 on 03/26/26 | 0.9564 on 03/03/26 | ||
| High | 0.40 on 12/29/17 | 1.3200 on 03/18/26 | 1.1100 on 03/18/26 | ||
| 3-Month | |||||
| %Chg | -26.35% since 09/29/17 | -11.19% since 12/31/25 | -25.09% since 12/31/25 | ||
| Low | 0.26 on 12/29/17 | 1.0000 on 03/26/26 | 0.7282 on 01/27/26 | ||
| High | 0.44 on 10/10/17 | 1.4900 on 01/05/26 | 1.4300 on 01/05/26 | ||
| 6-Month | |||||
| %Chg | -55.17% since 06/29/17 | -4.03% since 10/01/25 | -50.25% since 10/01/25 | ||
| Low | 0.26 on 12/29/17 | 1.0000 on 03/26/26 | 0.7282 on 01/27/26 | ||
| High | 0.65 on 07/03/17 | 1.9700 on 10/09/25 | 3.6800 on 10/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,885 | 11,901 | 11,734 | ||
| Shares Outstanding, K | 45,710 | 10,086 | 11,734 | ||
| Annual Sales | 0 | 120,000 | 50,000 | ||
| Annual Net Income | -23,550,000 | -8,270,000 | -1,840,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -6,080,000 | -2,530,000 | N/A | ||
| 60-Month Beta | 1.99 | 1.99 | -0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 08/14/17 | -0.58 on 11/07/25 | N/A | ||
| Latest Earnings Date | 03/21/18 | 04/03/26 | 04/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||